Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease associated with increased risk of cardiovascular disease (CVD). Treatment for CVD may involve pharmacological agents that antagonise beta adrenergic receptors. These receptors may play an important role in immunology,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Musculoskelet Dis
Asıl Yazarlar: Abuhelwa, Ahmad Y., Foster, David J. R., Manning-Bennett, Arkady, Sorich, Michael J., Proudman, Susanna, Wiese, Michael D., Hopkins, Ashley M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047969/
https://ncbi.nlm.nih.gov/pubmed/33912249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X211009020
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller